Using Accenture's public filings…
Full research prompt
Using Accenture's public filings (10-K, 10-Q), earnings call transcripts, and analyst reports, compile FY2023–FY2025 financial performance data covering revenue (~$69.7B in FY2025), operating margin, EPS, free cash flow, and bookings trends. Include Q1 FY2026 results ($18.7B revenue), organic growth rates by geography, and how GenAI bookings have contributed to the forward pipeline. Produce a multi-year financial summary table with key metrics.
From Accenture Company Overview: Business Segments, Financials, and Global Market Position (2026)
Accenture leads as the largest AI beneficiary in professional services yet faces the highest exposure to disruption. Its scale amplifies gains from AI-driven consulting but vulnerabilities in legacy segments could erode margins as clients automate routine work. Executives should assess if ACN's pivot matches their AI strategy.
Revenue Acceleration Through Managed Services and AI-Embedded Reinventions
Accenture accelerated revenue growth from 2% in FY2024 to 7% in FY2025 by shifting toward higher-margin managed services (9% growth vs. 5% consulting) and embedding GenAI into 60% of large deals, where real-time data from client operations enables agentic AI agents to automate workflows—tripling GenAI revenue to $2.7B while traditional consulting slowed amid economic caution. This mechanism creates a flywheel: AI pull-through drives 50% of GenAI projects into data modernization (up from negligible), boosting recurring managed services and extending deal durations beyond the typical 12-month consulting cycle.[1][2]
- FY2025 revenue: $69.7B (+7% LC/USD YoY); FY2024: $64.9B (+2% LC); FY2023: $64.1B[1]
- Managed services: $34.6B (+9% LC FY2025); consulting: $35.1B (+5% LC); 80% of large deals multi-service[3]
- GenAI revenue: $2.7B (tripled YoY); bookings: $5.9B (doubled YoY), across 6,000+ projects[1]
Implication for competitors: Pure consulting firms lack Accenture's data moat from managed services (53% of FY2025 revenue), making AI scaling harder—new entrants must partner early or risk commoditization in point solutions.
Margin Resilience Amid Optimization Costs
Accenture held adjusted operating margins steady at 15.5-15.6% across FY2024-FY2025 despite $1B+ in business optimization (talent rotation, impairments) by increasing fixed-price work to 60% (up 10pp in 3 years), which shifts risk to clients while leveraging SynOps AI platform for 20-30% productivity gains in operations. GAAP margins dipped slightly in FY2025 due to one-offs, but adjusted EPS grew 8% via share buybacks ($4.6B).[1]
- FY2025 adj. op. margin: 15.6% (+10bps YoY); GAAP: 14.7% (-10bps); FY2024 adj.: 15.5%, GAAP: 14.8%; FY2023 GAAP: 13.7%[4]
- Adj. diluted EPS: $12.93 (+8% YoY); GAAP: $12.15 (+6%); FY2024 adj.: $11.95 (+2%), GAAP: $11.44 (+6%)[1]
- Optimization costs: $615M FY2025 (90bps impact), $438M FY2024 (70bps)[1]
Implication for competitors: Offshore-heavy rivals face 13-15% attrition (Accenture at 13% FY2024); fixed-price AI tools like GenWizard provide defensibility, but require $3B-scale R&D (Accenture's FY2023-25 commitment).
Free Cash Flow Surge Funds AI and Returns
Free cash flow jumped 26% to $10.9B in FY2025 (OCF $11.5B minus $0.6B capex) via 92% utilization and DSOs at 47 days, enabling $8.3B shareholder returns (+7% YoY) while funding $1.5B acquisitions and $800M R&D—mechanism: AI agents in delivery (e.g., mySecurity) cut costs 20-30%, converting 1.4x net income to FCF.[1]
- FY2025 FCF: $10.9B (FCF/net income 1.4x); FY2024: $8.6B; FY2023 proxy ~$9.0B (OCF $9.5B minus $0.5B)[4]
- Returns: Dividends $3.7B ($5.92/share, +15%); repurchases $4.6B (14.1M shares); authority $7.9B[1]
Implication for competitors: Cash-rich incumbents like Cognizant ($2.7B FCF FY2025) can match returns, but Accenture's 149% cash conversion funds AI moat-building without debt.
Bookings Stability Masks AI Pull-Through Strength
Bookings dipped 1% to $80.6B in FY2025 (book-to-bill 1.2x) from FY2024's record $81.2B (+14% LC), but GenAI doubled to $5.9B (7% of total), with 129 deals >$100M (+19 YoY)—pipeline mechanism: RPO up to $34B (+13%), 66% billable in FY2026, as AI extends contracts via data platforms.[1]
- FY2025: $80.6B (-1% LC/USD); consulting $37.6B, managed $43.0B; FY2024: $81.2B[4]
- Q1 FY2026: $20.9B (+10% LC), book-to-bill 1.1x; advanced AI $2.2B (+76% YoY)[2]
Implication for competitors: Volume players win short deals, but Accenture's 305 diamond clients (largest relationships) lock in multi-year AI revenue.
Q1 FY2026 Momentum and Geographic Divergence
Q1 FY2026 revenue hit $18.7B (+5% LC, top of guide), with Asia Pacific (+9%) outpacing Americas/EMEA (+4% each) via banking/media demand; organic ~4% (ex-1% federal drag). Managed services (+7%) led, signaling outsourcing rebound.[2][5]
- Geo (LC): Americas 4% ($9.1B), EMEA 4% ($6.9B), Asia Pac 9% ($2.7B)
- Industries (LC): Fin Svcs +12% ($3.6B), CMT +8% ($3.1B), Products +4% ($5.7B), HPS +1% ($3.8B), Resources +2% ($2.5B)[2]
- Adj. op. margin 17.0% (+30bps); adj. EPS $3.94 (+10%); FCF $1.5B[2]
Implication for competitors: Federal cuts hit all (ex-1-1.5% FY26 drag), but Asia's AI infra boom favors global scalers.
GenAI's Pipeline Dominance
GenAI/advanced AI bookings hit $5.9B FY2025 (doubled), $2.2B Q1 FY2026 (+76% YoY), fueling 50% data pull-through and $34B RPO—mechanism: 77K AI pros (nearing 80K) deploy reusable agents (3K+), shifting clients from PoCs to enterprise-scale (11K projects, $4.8B revenue to-date). Now embedded everywhere, no longer isolated metric.[5]
- Cumulative: $11.5B bookings, $4.8B revenue since Q3 FY23 ($100M start)[5]
- Q1 FY26 revenue: $1.1B (+120% YoY); 1,300+ clients, +100/quarter[2]
Implication for competitors: $70B TAM by 2029 (40% CAGR); laggards need $3B investments like Accenture's to catch AI readiness gap.[2]
| Metric | FY2023 | FY2024 | FY2025 | Q1 FY2026 |
|---|---|---|---|---|
| Revenue ($B) | 64.1 | 64.9 (+2% LC) | 69.7 (+7% LC) | 18.7 (+5% LC) |
| Adj. Op. Margin | ~15.4% | 15.5% | 15.6% | 17.0% |
| Adj. Diluted EPS | ~11.67 | 11.95 (+2%) | 12.93 (+8%) | 3.94 (+10%) |
| FCF ($B) | ~9.0 | 8.6 | 10.9 | 1.5 |
| New Bookings ($B) | ~72.2 | 81.2 (+14% LC) | 80.6 (-1% LC) | 20.9 (+10% LC) |
Recent Findings Supplement (March 2026)
FY2025 Full Year Results (Reported Sep 25, 2025)
Accenture's FY2025 (ended Aug 31, 2025) revenue hit $69.7 billion, up 7% in local currency (LC) from FY2024's $64.9 billion, driven by broad-based growth across geographies and managed services (+9% LC), with GenAI bookings nearly doubling to $5.9 billion and contributing to a tripling of advanced AI revenue to $2.7 billion—creating a forward pipeline for scaled enterprise transformations as clients shift from proofs-of-concept to end-to-end AI integration.[1][2][3]
- Revenue: $69.7B (+7% LC / +7% USD YoY); GAAP op margin 14.7% (-10 bps); adjusted 15.6% (+10 bps); GAAP EPS $12.15 (+6%); adjusted $12.93 (+8%)
- FCF: $10.9B (+26% YoY); New bookings: $80.6B (-1% LC), book-to-bill 1.2x[1]
- Organic growth (LC): Americas +9%, EMEA +6%, Asia Pacific +4%; Industries: Financial Services +10%, Products +8%[1]
Implication for competitors: Accenture's data moat in real-time client transaction insights enables faster AI-led reinvention deals (129 deals >$100M), outpacing pure-play AI firms lacking services scale; new entrants need ecosystem partnerships to match this pipeline velocity.
Q1 FY2026 Results (Reported Dec 18, 2025)
Q1 FY2026 revenue reached $18.7 billion, +5% LC (top of prior guidance), powered by 33 mega-deals (>$100M bookings) and advanced AI bookings surging 76% YoY to $2.2B (last reported quarter as AI embeds across all work), with revenues +120% to $1.1B—bolstering the pipeline as 50%+ of AI projects spawn data follow-ons amid a $70B TAM growing 40%+ annually.[2][4]
- Revenue: $18.74B (+5% LC / +6% USD); GAAP op margin 15.3% (-140 bps due to $250M optimization); adjusted 17.0% (+30 bps); GAAP EPS $3.54 (-1%); adjusted $3.94 (+10%)
- FCF: $1.5B; New bookings $20.9B (+10% LC), book-to-bill 1.1x; Advanced AI bookings $2.2B (+76%)[2]
- Organic growth LC: Geography - Americas +4% ($9.1B), EMEA +4% ($6.9B), Asia Pacific +9% ($2.7B); Industry - Fin Svcs +12%, CMT +8%; Type of work - Consulting +3%, Managed Svcs +7%[4]
Implication for competitors: Q1's 83% YoY jump in shareholder returns ($3B, incl. $2.3B buybacks) via superior FCF conversion (1.4x net income) highlights operational leverage from AI upskilling 779k employees; rivals face talent rotation barriers without Accenture's 44M training hours scale.
Multi-Year Financial Summary (FY2023–FY2025 + Q1 FY2026)
| Metric | FY2023 | FY2024 | FY2025 | Q1 FY2026 |
|---|---|---|---|---|
| Revenue ($B) | 64.1 (+8% LC) | 64.9 (+2% LC) | 69.7 (+7% LC) | 18.7 (+5% LC) |
| Adj. Op. Margin (%) | 15.4 | 15.5 | 15.6 | 17.0 |
| Adj. EPS ($) | 11.67 | 11.95 | 12.93 | 3.94 |
| Free Cash Flow ($B) | 9.0 | 8.6 | 10.9 | 1.5 |
| New Bookings ($B) | 72.2 | 81.2 | 80.6 | 20.9 |
| Book-to-Bill (TTM) | N/A | 1.3 | 1.2 | 1.1 |
GenAI/advanced AI drove FY2025 bookings to $5.9B (from $3B FY2024), with Q1 FY2026 at $2.2B signaling sustained pipeline strength despite federal headwinds.[1]
Implication for market entry: Stable margins (15.4–15.6%) amid revenue acceleration show pricing power from AI differentiation; incumbents like TCS (higher margins) compete on cost, but Accenture's 1.2–1.3x book-to-bill sustains multi-year visibility.
Bookings Trends and GenAI Pipeline Impact
New bookings peaked at $81.2B in FY2024 (book-to-bill 1.3x) before moderating to $80.6B FY2025 (1.2x), with Q1 FY2026 at $20.9B (1.1x)—offset by GenAI's near-doubling to $5.9B FY2025, fueling 1-in-2 AI deals into data projects and ecosystem growth (top 10 partners >60% revenue).[4][6]
- TTM book-to-bill: FY23 1.3x, FY24 1.1x? (historical: FY20–25 range 1.1–1.3x); 129 FY2025 mega-deals (+ vs. FY24's 125)[4]
Implication for competitors: GenAI's maturation (no longer isolated reporting post-Q1 FY26) embeds across pipeline, creating sticky multi-year revenue; entrants must build AI agents (3,000+ deployed) to compete in $70B TAM.
FY2026 Guidance and Forward Outlook
Guidance reconfirmed post-Q1: 2–5% LC revenue growth (3–6% ex-U.S. federal; ~4.5% organic top-end w/ 1.5% inorganic), adj. op margin 15.7–15.9% (+10–30 bps), adj. EPS $13.52–13.90 (+5–8%), FCF $9.8–10.5B, $9.3B+ returns.[2][4]
Implication for investors/competitors: AFS drag (mid-teens contraction) tests resilience, but AI momentum (1,300+ clients) and 80k AI pros goal position for upside; challengers need federal exposure hedges. Confidence high (recent data); prior years from historical filings.[5][3]